Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Chromocell Therapeutics Corporation

CHRO
Current price
0.64 USD -0.011 USD (-1.73%)
Last closed 0.62 USD
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange NYSE
Capitalization 5 337 080 USD
Yield for 12 month -86.67 %
1Y
3Y
5Y
10Y
15Y
CHRO
21.11.2021 - 28.11.2021

Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the development and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain and acute and chronic eye pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey. Address: 4400 Route 9 South, Freehold, NJ, United States, 07728

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

8.5 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-2 579 418 USD

Last Year

Current Quarter

-13 USD

Last Quarter

-466 606 USD

Key Figures CHRO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA
Operating Margin TTM
PE Ratio
Return On Assets TTM -412.8 %
PEG Ratio
Return On Equity TTM
Wall Street Target Price 8.5 USD
Revenue TTM
Book Value -0.031 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.68 USD
Diluted Eps TTM -1.68 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CHRO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CHRO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CHRO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -3.5773
Price Book MRQ 4.1077

Financials CHRO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CHRO

For 52 weeks

0.52 USD 6 USD
50 Day MA 0.99 USD
Shares Short Prior Month 3 343
200 Day MA 1.8 USD
Short Ratio 0.74
Shares Short 21 834
Short Percent 0.5 %